-+ 0.00%
-+ 0.00%
-+ 0.00%

China Regenerative Medicine (08158) Announces Interim Results Revenue of HK$41.734 million, a year-on-year increase of 52.36%

Zhitongcaijing·08/21/2026 11:17:06
Listen to the news

According to the Zhitong Finance App, China Regenerative Medicine (08158) announced its 2026 interim results, with revenue of HK$41.734 million, up 52.36% year on year; net profit of HK$4.623 million, which is basically the same; profit per share of HK 1.51 cents.